LOS ANGELES, Aug. 24, 2023 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 29, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”)…Read More
Glancy Prongay Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aldeyra Therapeutics Inc ALDX Aldeyra Therapeutics NASDAQALDX
